Carbohydrate intake and nonalcoholic fatty liver disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 16, Issue 4, 2013, Pages 446-452

  Neuschwander Tetri, Brent A ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Fructose; Glucose; Lipogenesis; Nonalcoholic steatohepatitis

Indexed keywords

CARBOHYDRATE; FRUCTOSE; PENTOXIFYLLINE; URIC ACID;

CARBOHYDRATE INTAKE; CLINICAL RESEARCH; DRUG EFFECT; EPIDEMIOLOGICAL DATA; HUMAN; LIPOGENESIS; LIVER INJURY; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW;

ANIMALS; BEVERAGES; CLINICAL TRIALS AS TOPIC; DIETARY CARBOHYDRATES; FATTY LIVER; FIBROSIS; HUMANS; LIPOGENESIS; LIVER; URIC ACID;

ANIMALIA;

EID: 84880330917     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328361c4d1     Document Type: Review

References (35)

1. Wang S, Soni KG, Semache M, et al. Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab 2008; 95:117-126.
2. Teusink B, Voshol PJ, Dahlmans VE, et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissuespecific fatty acid uptake. Diabetes 2003; 52:614-620.
3. Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005; 115:1343-1351.
4. Diraison F, Moulin P, Beylot M. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during nonalcoholic fatty liver disease. Diabetes Metab 2003; 29:478-485.
5. Pickens MK, Ogata H, Soon RK, et al. Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet. Liver Int 2010; 30:1229-1239.
6. Ren L-P, Chan SMH, Zeng X-Y, et al. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. PLoS One 2012; 7:e30816.
7. Peter A, Stefan N, Cegan A, et al. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab 2011; 96:E1126-E1130.
8. Speliotes EK, Yerges-Armstrong LM, Wu J, et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7:e1001324.
9. Santoro N, Zhang CK, Zhao H, et al. Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 2012; 55:781-789.
10. Bechmann LP, Gastaldelli A, Vetter D, et al. Glucokinase links Krü ppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology 2012; 55:1083-1093.
11. Rabøl R, Petersen KF, Dufour S, et al. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc Natl Acad Sci U S A 2011; 108:13705-13709.
12. Tappy L, Lê K-A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010; 90:23-46.
13. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for nonalcoholic fatty liver disease. J Hepatol 2008; 48:993-999.
14. Abdelmalek MF, Lazo M, Horska A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 2012; 56:952-960.
15. Lanaspa M.A. Cicerchi C, Garcia G, et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One 2012; 7:e48801.
16. Lanaspa M.A. Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress:potential role in fructose-dependent and -independent fatty liver. J Biol Chem 2012; 287:40732-40744.
17. Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010; 51:1961-1971.
18. Tappy L, Mittendorfer B. Fructose toxicity:is the science ready for public health actions? Curr Opin Clin Nutr Metab Care 2012; 15:357-361.
19. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009; 119:1322-1334.
20. Stanhope KL, Bremer AA, Medici V, et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J Clin Endocrinol Metab 2011; 96:E1596-E1605.
21. Maersk M, Belza A, Stødkilde-Jørgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot:A 6-mo randomized intervention study. Am J Clin Nutr 2012; 95:283-289.
22. Sevastianova K, Santos A, Kotronen A, et al. Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans. Am J Clin Nutr 2012; 96:727-734.
23. Silbernagel G, Machann J, Unmuth S, et al. Effects of 4-week very-highfructose/ glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids:an exploratory trial. Br J Nutr 2011; 106:79-86.
24. Jin R, Le N-A, Liu S, et al. Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. J Clin Endocrinol Metab 2012; 97:E1088-E1098.
25. Lê KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009; 89:1760-1765.
26. Davis JN, Lê K-A, Walker RW, et al. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am J Clin Nutr 2010; 92:1522-1527.
27. Kumari M, Schoiswohl G, Chitraju C, et al. Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab 2012; 15:691-702.
28. Pickens MK, Yan JS, Ng RK, et al. Dietary sucrose is essential to the development of liver injury in the MCD model of steatohepatitis. J Lipid Res 2009; 50:2072-2082.
29. Abu-Elheiga L, Wu H, Gu Z, et al. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions. J Biol Chem 2012; 287:12578-12588.
30. Aoi W, Naito Y, Hang LP, et al. Regular exercise prevents high-sucrose dietinduced fatty liver via improvement of hepatic lipid metabolism. Biochem Biophys Res Commun 2011; 413:330-335.
31. Truswell AS, Seach JM, Thorburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating effect of glucose. Am J Clin Nutr 1988; 48:1424-1430.
32. Bergheim I, Weber S, Vos M, et al. Antibiotics protect against fructoseinduced hepatic lipid accumulation in mice:role of endotoxin. J Hepatol 2008; 48:983-992.
33. Wagnerberger S, Spruss A, Kanuri G, et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. Br J Nutr 2012; 107:1727-1738.
34. Roncal-Jimenez CA, Lanaspa M.A. Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism 2011; 60:1259-1270.
35. Massart J, Robin MA, Noury F, et al. Pentoxifylline aggravates fatty liver in obese and diabetic ob/ob mice by increasing intestinal glucose absorption and activating hepatic lipogenesis. Br J Pharmacol 2012; 165:1361-1374.